Patent details

EP3127545 Title: ANTI-TUMOR DRUG CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER

Basic Information

Publication number:
EP3127545
PCT Application Number:
JP2015060645
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157743519
PCT Publication Number:
WO2015152409
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-TUMOR DRUG CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER
French Title of Invention:
MÉDICAMENT ANTI-TUMORAL CONTENANT UN COMPOSÉ TAXANE, ET RENFORÇATEUR D'EFFET ANTI-TUMORAL
German Title of Invention:
ANTITUMORWIRKSTOFF MIT TAXANVERBINDUNG UND ANTITUMORWIRKUNGSVERSTÄRKER
SPC Number:

Dates

Filing date:
03/04/2015
Grant date:
03/06/2020
EP Publication Date:
08/02/2017
PCT Publication Date:
08/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/06/2020
EP B1 Publication Date:
03/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/04/2021
Expiration date:
03/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/05/2020
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27, Kanda Nishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

Name:
OKABE, Hiroyuki
Address:
Japan (JP)

Priority

Priority Number:
2014078243
Priority Date:
04/04/2014
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/337; A61K 31/513; A61K 31/7072; A61P 1/00; A61P 11/00; A61P 15/00; A61P 35/00; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202023
Publication date:
03/06/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages